Literature DB >> 29732605

Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients.

Miki Takahara1, Yui Hirata1, Toshihiro Nagato1, Kan Kishibe1, Akihiko Katada1, Tatsuya Hayashi1, Mari Kishibe2, Akemi Ishida-Yamamoto2, Yasuaki Harabuchi1.   

Abstract

Pustulosis palmaris et plantaris (PPP) and pustulotic arthro-osteitis (PAO) are tonsil-related diseases. Treatment outcome of tonsillectomy and prognostic factors influencing the outcome have not been analyzed quantitatively. We evaluated those using the Palmoplantar Pustulosis Area and Severity Index (PPPASI). At 1, 3, 6, 12, 24 and more than 24 months post-tonsillectomy, 20 (31%), 34 (48%), 70 (60%), 57 (80%), 36 (95%) and 23 (96%) patients realized 80% or more improvement of PPP skin lesions, respectively, and eight (17%), 23 (36%), 30 (50%), 38 (79%), 12 (100%) and four (100%) patients showed 80% or more improvement of PPPASI (i.e. PPPASI% ≥ 80%), respectively. At 1, 3, 6, 12 and more than 12 months post-tonsillectomy, 19 (73%), 21 (66%), 27 (73%), 19 (79%) and 15 (83%) patients realized a disappearance of PAO-induced arthralgia, respectively. Kaplan-Meier analysis of 80 patients with PPP revealed that, at 12 and 24 months post-tonsillectomy, lesions disappeared (i.e. PPPASI = 0) in 38% and 66% of patients, respectively, and lesions improved by 80% or more (i.e. PPPASI% ≥ 80%) in 71% and 95% of patients, respectively. The log-rank test and univariate and multivariate analyses showed that smoking cessation post-tonsillectomy and PAO were significant predictive factors for the early disappearance of skin lesions. This report is the first demonstrating objective evidence of the great efficacy of tonsillectomy to improve PPP skin lesions. Even post-tonsillectomy, smoking inhibited the early disappearance of the lesions.
© 2018 Japanese Dermatological Association.

Entities:  

Keywords:  palmoplantar pustulosis; pustulotic arthro-osteitis; smoking; tonsil-related disease; tonsillectomy

Mesh:

Year:  2018        PMID: 29732605     DOI: 10.1111/1346-8138.14348

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

1.  Prognostic Factors and Long-Term Efficacy of Tonsillectomy in 17 Patients with Pustulotic Arthro-Osteitis.

Authors:  Yuji Kan; Yasuyuki Sumikawa; Tokimasa Hida; Saeko Ajiki; Hisashi Uhara
Journal:  Eurasian J Med       Date:  2020-02

Review 2.  Recent advances in the immunological understanding of association between tonsil and immunoglobulin A nephropathy as a tonsil-induced autoimmune/inflammatory syndrome.

Authors:  Yasuaki Harabuchi; Miki Takahara
Journal:  Immun Inflamm Dis       Date:  2019-04-07

Review 3.  Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.

Authors:  Magdalena Misiak-Galazka; Joanna Zozula; Lidia Rudnicka
Journal:  Am J Clin Dermatol       Date:  2020-06       Impact factor: 7.403

Review 4.  Involvement of Molecular Mechanisms between T/B Cells and IL-23: From Palmoplantar Pustulosis to Autoimmune Diseases.

Authors:  Takemichi Fukasawa; Asako Yoshizaki-Ogawa; Atsushi Enomoto; Kiyoshi Miyagawa; Shinichi Sato; Ayumi Yoshizaki
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

Review 5.  Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.

Authors:  Toshiyuki Yamamoto
Journal:  Clin Pharmacol       Date:  2021-06-23

6.  Tonsillectomy as an effective treatment for arthralgia of SAPHO syndrome.

Authors:  Sena Horiguchi; Takeshi Fujita; Koji Kinoshita; Katsumi Doi
Journal:  J Surg Case Rep       Date:  2020-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.